Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Narla Mohandas is Vice President for Research at New York Blood Center, New York, USA. He received his doctoral degree from Washington University, St. Louis, USA in Chemical Engineering. After completing post-doctoral training in hematology research with Dr Marcel Bessis, Institute of Cellular Pathology in Paris, France, he joined the Faculty of Laboratory Medicine at University of California, San Francisco where he spent 13 years. In 1989, he moved to Lawrence Berkeley National Laboratory, University of California to head the Hematopoiesis group. During his 12-year tenure at the Berkeley Laboratory he also served as Interim Director of Human Genome Project for three years. In 2001, he moved to the New York Blood Center.
Dr Mohandas’ scientific interests during his 45-year research career have focused on red cell physiology and pathology. In particular, his efforts have contributed to improved understanding of the molecular and structural basis for red cell membrane disorders, developing detailed mechanistic insights into pathophysiology of thalassemias and sickle cell disease, characterizing structural and functional changes induced in red cells by the malarial parasite, plasmodium falciparum. His research efforts during last ten years are focused on molecular understanding of normal and disordered human erythropoiesis including Diamond-Blackfan anemia and Myelodysplasia.
Dr Mohandas served as a member of the National Institutes of Health Hematology study section for 18 years and is currently member of the NHLBI Advisory Council. He has been a member of numerous committees including the Executive committee of American Society of Hematology. He served as Associate Editor of Blood from 2003–2012 and is currently Editor-in-Chief of Blood Cells, Molecules and Disease and of Current Opinion in Hematology.
Dr Sandrina Kinet received her PhD in Biology from the University of Liège, Belgium. After completing two post-doctoral training programs in the fields of Evolutionary Biology and Immunology in France, she was recruited as a tenured CNRS staff scientist at the Institut de Génétique Moléculaire in Montpellier, France. Her initial research efforts focused on evaluating the importance of the metabolism in the functionality of human hematopoietic cells. Her major interest rapidly evolved into the study of how nutrient availability and utilization regulate hematopoietic stem cell (HSC) differentiation towards the erythroid lineage. This work has contributed to our understanding of the impact of metabolic modulation during erythroid cell differentiation. Her long-term goal is to dissect the mechanisms via which specific metabolites modulate both physiological and pathological erythropoiesis. Additionally, over the past few years, she has invested a significant effort in promoting the “transmission” of scientific knowledge to the community, teaching graduate students at the University of Montpellier and promoting the success of women in science through graduate student and community initiatives.
M. Luisa Iruela-Arispe
After completing her Ph.D. and post-doctoral training, Dr Iruela-Arispe joined Harvard Medical School as Assistant Professor in the Department of Pathology. In 1998, she was recruited to UCLA where she ascended through the professorial ranks culminating in Distinguished Professor in Molecular, Cell and Developmental Biology. At UCLA she became the first women to direct the prestigious Molecular Biology Institute and also chaired the Interdepartmental Molecular Biology Graduate program, the main graduate program in biosciences with over 150 graduate students. She taught Cell Biology to undergraduate students for 20 years and built an internationally recognized research group in angiogenesis and vascular regeneration that was continuously funded by the NIH. She was the founding director of the Vascular Biology Training Program at UCLA that under her leadership was supported by a T32 for 20 years. Her research efforts amount to approximately 200 published peer review research articles and reviews with substantial contributions to the field of vascular biology. She was president of the North American Vascular Biology Organization and contributed in several leadership forms to other organizations and societies such as AHA, AACR, and ASCB. In the Fall of 2019, Dr Iruela-Arispe was recruited to Northwestern to Chair the Department of Cell and Developmental Biology and continue to make breakthroughs in her research area. Currently, she is also a member of the NHLBI Council to the Director and the NCI Intramural Advisory Board.